The reduction of ROS will enhance the translocation of β-catenin, upregulating the stemness-related genes (KFL4, NANOG, OCT4, SOX2, CD13, and CD44) in HCC (Li et al., 2019). This evidence concerns the gene CD44 and hepatocellular carcinoma.